Cargando…

Clinical efficacy of dupilumab in the treatment of severe chronic rhinosinusitis: The first case outside of a clinical trial

Treatment options for severe CRSwNP are limited. Dupilumab is a safe, well‐tolerated, and effective alternative in patients with poor control of symptoms, corticosteroid‐dependent disease, and high rates of recurrence of nasal polyps after surgery.

Detalles Bibliográficos
Autores principales:	Trimarchi, Matteo, Indelicato, Pietro, Vinciguerra, Alessandro, Bussi, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981721/ https://www.ncbi.nlm.nih.gov/pubmed/33768860 http://dx.doi.org/10.1002/ccr3.3792

Ejemplares similares

A prospective study on the efficacy of dupilumab in chronic rhinosinusitis with type 2 inflammation
por: Trimarchi, Matteo, et al.
Publicado: (2022)

Long-term results of a balloon-assisted endoscopic approach in failed dacryocystorhinostomies
por: Vinciguerra, Alessandro, et al.
Publicado: (2021)

A case of endonasal balloon‐assisted dacryoplasty after failure of endonasal dacryocystorhinostomy
por: Indelicato, Pietro, et al.
Publicado: (2020)

Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps
por: Hellings, Peter W., et al.
Publicado: (2022)

Dupilumab: Clinical Efficacy of Blocking IL-4/IL-13 Signalling in Chronic Rhinosinusitis with Nasal Polyps
por: Kariyawasam, Harsha H, et al.
Publicado: (2020)

Proposal for a Structured Outpatient Clinic for Dupilumab Treatment in Chronic Rhinosinusitis with Nasal Polyps in the First Year of Treatment
por: Torretta, Sara, et al.
Publicado: (2022)

Multidisciplinary approach to lacrimal system diseases
por: Trimarchi, Matteo, et al.
Publicado: (2021)

The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan
por: Fujieda, Shigeharu, et al.
Publicado: (2020)

Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps
por: Kilty, Shaun J., et al.
Publicado: (2022)

Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps
por: Hopkins, Claire, et al.
Publicado: (2021)

Efficacy of Dupilumab in Concomitant Atopic Dermatitis and Chronic Rhinosinusitis With Nasal Polyps: A Preliminary Study
por: Nettis, Eustachio, et al.
Publicado: (2020)

Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status
por: Fujieda, Shigeharu, et al.
Publicado: (2021)

Real‐life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps
por: van der Lans, Rik Johannes Leonardus, et al.
Publicado: (2021)

COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab
por: Förster-Ruhrmann, Ulrike, et al.
Publicado: (2020)

Dupilumab: An emerging therapy in allergic fungal rhinosinusitis()
por: Bulkhi, Adeeb A., et al.
Publicado: (2022)

Endoscopic and external dacryocystorhinostomy: A therapeutic proposal for distal acquired lacrimal obstructions
por: Vinciguerra, Alessandro, et al.
Publicado: (2022)

Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review
por: Nitro, Letizia, et al.
Publicado: (2022)

Clinical outcomes of dupilumab therapy in chronic rhinosinusitis with nasal polyps in a Canadian tertiary care rhinology practice
por: Grose, Elysia, et al.
Publicado: (2023)

Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date
por: Kim, Jean, et al.
Publicado: (2020)

AROMA: real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps
por: Siddiqui, Shahid, et al.
Publicado: (2022)

Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials
por: Bachert, Claus, et al.
Publicado: (2022)

Are atopy and eosinophilic bronchial inflammation associated with relapsing forms of chronic rhinosinusitis with nasal polyps?
por: Yacoub, Mona-Rita, et al.
Publicado: (2015)

Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID‐ERD: Results from two randomized placebo‐controlled phase 3 trials
por: Mullol, Joaquim, et al.
Publicado: (2021)

Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps
por: Gevaert, Philippe, et al.
Publicado: (2023)

Dupilumab‐induced skin‐associated side effects in patients with chronic rhinosinusitis with nasal polyposis
por: Chromy, David, et al.
Publicado: (2022)

Gene Expression Analysis in Patients with Cocaine-Induced Midline Destructive Lesions
por: Trimarchi, Matteo, et al.
Publicado: (2021)

A case report of allergic fungal rhinosinusitis managed with Dupilumab
por: Alotaibi, Naif H., et al.
Publicado: (2021)

Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps
por: Pelaia, Corrado, et al.
Publicado: (2023)

Dupilumab reduces local type 2 pro‐inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis
por: Jonstam, Karin, et al.
Publicado: (2019)

WITHDRAWN: Dupilumab: A review of potential in the treatment of Chronic rhinosinusitis with nasal polyps (CRSwNP)
por: Sree Sudha, T.Y., et al.
Publicado: (2020)

Management of chronic rhinosinusitis with nasal polyps in Samter triad by low-dose ASA desensitization or dupilumab
por: Bertlich, Mattis, et al.
Publicado: (2021)

Cost–Utility Analysis of Dupilumab for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Italy
por: De Corso, Eugenio, et al.
Publicado: (2022)

Comorbid asthma in patients with chronic rhinosinusitis with nasal polyps: did dupilumab make a difference?
por: Al-Ahmad, Mona, et al.
Publicado: (2023)

Exacerbation of Eosinophilic Granulomatosis With Polyangiitis After Administering Dupilumab for Severe Asthma and Eosinophilic Rhinosinusitis With Nasal Polyposis
por: Tanaka, Shunya, et al.
Publicado: (2022)

Conjunctivitis in dupilumab clinical trials
por: Akinlade, B., et al.
Publicado: (2019)

Effectiveness and Safety Profile of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Real-Life Data in Tertiary Care
por: Galletti, Cosimo, et al.
Publicado: (2023)

Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results
por: Bachert, Claus, et al.
Publicado: (2023)

Assessment of the rapid effect of dupilumab in two cases of severe asthma comorbid with recurrent eosinophilic chronic rhinosinusitis after endoscopic sinus surgery
por: Kai, Yoshiro, et al.
Publicado: (2021)

Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life
por: Nettis, Eustachio, et al.
Publicado: (2022)

Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics
por: Busse, William Walter, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cdq3rmj7g9qq0bvn4taeac3fp2